Toxicokinetics of recombinant human fibroblast growth factor 21 for injection in cynomolgus monkey for 3 months

Introduction: Recombinant human fibroblast growth factor 21 (FGF-21) is a potential therapeutic agent for multiple metabolic diseases. However, little is known about the toxicokinetic characteristics of FGF-21. Methods: In the present study, we investigated the toxicokinetics of FGF-21 delivered via...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chao, Jin, Lei, Bi, Jianing, Jin, Hongyi, You, Xinyi, Peng, Lulu, Fan, Haibing, Wang, Huan, Wang, Liangshun, Fan, Zhengkai, Wang, Xiaojie, Liu, Baohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242211/
https://www.ncbi.nlm.nih.gov/pubmed/37288111
http://dx.doi.org/10.3389/fphar.2023.1176136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242211/
https://www.ncbi.nlm.nih.gov/pubmed/37288111
http://dx.doi.org/10.3389/fphar.2023.1176136

Ejemplares similares